Biosimilars-Curb Your Enthusiasm

JAMA Oncol. 2017 Nov 1;3(11):1467-1468. doi: 10.1001/jamaoncol.2017.1530.

Authors

Y Tony Yang¹, Brian Chen², Charles L Bennett³

Affiliations

¹ Department of Health Administration and Policy, George Mason University, Fairfax, Virginia.
² Department of Health Services Policy and Management, University of South Carolina, Columbia.
³ Center for Medication Safety and Efficacy, University of South Carolina, Columbia.

PMID: 28594963
DOI: 10.1001/jamaoncol.2017.1530

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Biosimilar Pharmaceuticals / economics*
Cost Savings
Drug Industry / economics
Drug Industry / legislation & jurisprudence*
Humans
United States

Substances

Biosimilar Pharmaceuticals